Plant-derived glucose transport inhibitors with potential antitumor activity

Phytother Res. 2020 May;34(5):1027-1040. doi: 10.1002/ptr.6587. Epub 2019 Dec 10.

Abstract

Glucose, a key nutrient utilized by human cells to provide cellular energy and a carbon source for biomass synthesis, is internalized in cells via glucose transporters that regulate glucose homeostasis throughout the human body. Glucose transporters have been used as important targets for the discovery of new drugs to treat cancer, diabetes, and heart disease, owing to their abnormal expression during these disease conditions. Thus far, several glucose transport inhibitors have been used in clinical trials, and increasing numbers of natural products have been characterized as potential anticancer agents targeting glucose transport. The present review focuses on natural product glucose transport inhibitors of plant origin, including alkaloids, flavonoids and other phenolic compounds, and isoprenoids, with their potential antitumor properties also discussed.

Keywords: alkaloids; antitumor agents; flavonoids; glucose transport inhibitors; isoprenoids; natural products.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Glucose Transport Proteins, Facilitative / metabolism*
  • Humans
  • Neoplasms / drug therapy*
  • Plants / chemistry*

Substances

  • Antineoplastic Agents
  • Glucose Transport Proteins, Facilitative